Sponsored
Sponsored
Media Summary: For biotech investors, medical innovators, and AI technology leaders — this New to The Street interview from the New York Stock ... RADR®, or Response Algorithm for Drug Positioning & Rescue, is Biotech investors and oncology researchers:

Lantern Pharma Fourth Quarter Year - Detailed Analysis & Overview

For biotech investors, medical innovators, and AI technology leaders — this New to The Street interview from the New York Stock ... RADR®, or Response Algorithm for Drug Positioning & Rescue, is Biotech investors and oncology researchers: For biotech investors, healthcare innovators, and AI technology enthusiasts — this New to The Street interview from the New York ... 90% of new drug discoveries fail in the clinic, costing the industry billions in lost capital and For biotech investors, medical innovators, and AI researchers, this New to The Street reel highlights

Listen to the most recent conference call between the business and investors or financial analysts as they talk about the ...

Photo Gallery

Lantern Pharma | Fourth Quarter & Year-end 2024 Operating & Financial Results
Lantern Pharma Q4 2025 Earnings Call | AI-Driven Pipeline Expansion and Clinical Milestones
Lantern Pharma | Fourth Quarter 2022 Operating & Financial Results Conference Call
Lantern Pharma Advances Lung Cancer Trial After Positive FDA Feedback
Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform
Lantern Pharma Meets FDA to Advance AI-Driven Lung Cancer Trial | LTRN
Lantern Pharma Uses AI to Transform Cancer Drug Development | Breakthrough Trials & ZETA Platform
US FDA Clears LP-184: Lantern Pharma's Game-Changing AI Cancer Therapy Targets Solid Tumors
What is Lantern Pharma's RADR™ System, and How Does it Help with Cancer Drug Development?
Lantern Pharma (LTRN) Reports Q3 2025 Results | LP-184 Trial Hits All Endpoints
Lantern Pharma Launches Zeta AI to Target Rare Cancers and Accelerate Drug Development
Lantern Pharma Uses AI to Slash Cancer Drug Timelines | LP-184 Trial Success & Starlight Spinoff
View Detailed Profile
Lantern Pharma | Fourth Quarter & Year-end 2024 Operating & Financial Results

Lantern Pharma | Fourth Quarter & Year-end 2024 Operating & Financial Results

0:00 Introduction 7:40

Lantern Pharma Q4 2025 Earnings Call | AI-Driven Pipeline Expansion and Clinical Milestones

Lantern Pharma Q4 2025 Earnings Call | AI-Driven Pipeline Expansion and Clinical Milestones

Lantern Pharma Q4

Sponsored
Lantern Pharma | Fourth Quarter 2022 Operating & Financial Results Conference Call

Lantern Pharma | Fourth Quarter 2022 Operating & Financial Results Conference Call

Lantern's Q4

Lantern Pharma Advances Lung Cancer Trial After Positive FDA Feedback

Lantern Pharma Advances Lung Cancer Trial After Positive FDA Feedback

Lantern Pharma

Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform

Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform

Lantern Pharma

Sponsored
Lantern Pharma Meets FDA to Advance AI-Driven Lung Cancer Trial | LTRN

Lantern Pharma Meets FDA to Advance AI-Driven Lung Cancer Trial | LTRN

Lantern Pharma

Lantern Pharma Uses AI to Transform Cancer Drug Development | Breakthrough Trials & ZETA Platform

Lantern Pharma Uses AI to Transform Cancer Drug Development | Breakthrough Trials & ZETA Platform

For biotech investors, medical innovators, and AI technology leaders — this New to The Street interview from the New York Stock ...

US FDA Clears LP-184: Lantern Pharma's Game-Changing AI Cancer Therapy Targets Solid Tumors

US FDA Clears LP-184: Lantern Pharma's Game-Changing AI Cancer Therapy Targets Solid Tumors

Lantern Pharma

What is Lantern Pharma's RADR™ System, and How Does it Help with Cancer Drug Development?

What is Lantern Pharma's RADR™ System, and How Does it Help with Cancer Drug Development?

RADR®, or Response Algorithm for Drug Positioning & Rescue, is

Lantern Pharma (LTRN) Reports Q3 2025 Results | LP-184 Trial Hits All Endpoints

Lantern Pharma (LTRN) Reports Q3 2025 Results | LP-184 Trial Hits All Endpoints

Biotech investors and oncology researchers:

Lantern Pharma Launches Zeta AI to Target Rare Cancers and Accelerate Drug Development

Lantern Pharma Launches Zeta AI to Target Rare Cancers and Accelerate Drug Development

Lantern Pharma

Lantern Pharma Uses AI to Slash Cancer Drug Timelines | LP-184 Trial Success & Starlight Spinoff

Lantern Pharma Uses AI to Slash Cancer Drug Timelines | LP-184 Trial Success & Starlight Spinoff

For biotech investors, healthcare innovators, and AI technology enthusiasts — this New to The Street interview from the New York ...

Lantern Pharma Reports Positive LP-184 Cancer Trial Data - Advances Precision Oncology Program

Lantern Pharma Reports Positive LP-184 Cancer Trial Data - Advances Precision Oncology Program

Biotech investors:

Lantern Pharma (LTRN): AI Oncology Platform Targeting a Multi-Billion Dollar Drug Discovery Problem

Lantern Pharma (LTRN): AI Oncology Platform Targeting a Multi-Billion Dollar Drug Discovery Problem

90% of new drug discoveries fail in the clinic, costing the industry billions in lost capital and

Lantern Pharma Demonstrates ZETA AI Designing Cancer Drugs | The Future of AI-Driven Drug Discovery

Lantern Pharma Demonstrates ZETA AI Designing Cancer Drugs | The Future of AI-Driven Drug Discovery

For biotech investors, medical innovators, and AI researchers, this New to The Street reel highlights

Lantern Pharma Wins FDA Orphan Drug Status for LP-284 Cancer Therapy | NewsOut

Lantern Pharma Wins FDA Orphan Drug Status for LP-284 Cancer Therapy | NewsOut

Biotech and healthcare investors:

Lantern Pharma Inc Q4 2021 | Earnings Call Update #earningscall

Lantern Pharma Inc Q4 2021 | Earnings Call Update #earningscall

Listen to the most recent conference call between the business and investors or financial analysts as they talk about the ...

Lantern Pharma Shares Positive LP-184 Phase 1 Cancer Data | Precision Oncology with AI | NewsOut

Lantern Pharma Shares Positive LP-184 Phase 1 Cancer Data | Precision Oncology with AI | NewsOut

Biotech investors:

Related Video Content

Lantern | Unlock the full internet information

Lantern is more than a VPN. It's designed to overcome the toughest internet restrictions, surpassing the capabilities...

Lantern · GitHub information

Open-source VPN for speed, privacy, and censorship circumvention. Free to download on Android, iOS, Windows, macOS,...

Lantern - Private Internet for All - Amazon Web Services information

Lantern delivers private, fast, reliable and secure access to the open internet. One click to a private and secure...

Download Lantern (free) for Windows, macOS, Android, APK, iOS information

May 22, 2026 · Bypass internet restrictions effortlessly with Lantern—a lightweight, user-friendly tool that ensures...

Lantern: Fast, Secure VPN - Apps on Google Play information

Use Lantern to unblock and enjoy unrestricted access to streaming platforms, social media, news sites, AI, and...

Sponsored